IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
about
IL-4 and IL-13 signaling in allergic airway diseaseCytokines in psoriasisA molecular perspective on TH2-promoting cytokine receptors in patients with allergic disease.CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary FibroblastsRPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human StudyImportance of cytokines in murine allergic airway disease and human asthma.IL-13Rα2 has a protective role in a mouse model of cutaneous inflammationDownregulation of glutathione S-transferase pi in asthma contributes to enhanced oxidative stressAssociation between Prediagnostic Allergy-Related Serum Cytokines and Glioma.Development and validation of an ELISA at acidic pH for the quantitative determination of IL-13 in human plasma and serum.IL-13 receptor α2 contributes to development of experimental allergic asthma.Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor α2Constitutive production of IL-13 promotes early-life Chlamydia respiratory infection and allergic airway disease.The potential for genetically altered microglia to influence glioma treatment.Tricellulin is regulated via interleukin-13-receptor α2, affects macromolecule uptake, and is decreased in ulcerative colitis.Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.Assessment of near-infrared fluorophores to study the biodistribution and tumor targeting of an IL13 receptor α2 antibody by fluorescence molecular tomography.Commentary: IL-4 and IL-13 receptors and signalingModulation of pulmonary fibrosis by IL-13Rα2.Equilibrium and kinetic analysis of human interleukin-13 and IL-13 receptor alpha-2 complex formation.Unique IL-13Rα2-based HIV-1 vaccine strategy to enhance mucosal immunity, CD8(+) T-cell avidity and protective immunity.
P2860
Q26859510-C5DC8678-EFC2-41ED-8D02-83FA17DBC27FQ28255491-A44D4F4F-FE73-4189-A4D2-B6C9554FDEC2Q30406072-4DEB2812-1482-443D-A8E3-B2DD798A1B2AQ33756881-FD0FBE93-49CE-4089-BB23-693747C3B679Q33844398-A39A43FD-88B2-477A-9076-B073BE2EB3FCQ34003580-A89E5DF8-B1AC-425C-9E09-97AD5F6DA6CFQ34610797-2517B7A6-29E8-4203-9F08-DEF8DCA30319Q35190062-BC66BC7C-2833-4266-9A8B-123867F5491EQ35767586-0FC1078E-4D24-4C0F-9522-B128543E8EF7Q37260303-BC8EF378-43A5-4C80-BCAE-0D4AF9AB9EA8Q37333077-8703D683-A17C-4C00-983C-851D02531B58Q37705711-0B4A3CCD-5FA4-4431-9FA8-2F1CB4AE3AACQ37847719-4A540DC3-0776-41D1-B6AA-12016D624F94Q38139120-DC333B68-8B47-4BD1-B189-1D9193D2EE9FQ38671207-E7B9D94B-3FD0-4C9F-ABDE-23DE6AFB7F63Q39059671-0BBEDB52-1363-4845-8F23-2A4C0140E42EQ41342471-686E8491-CF5A-462B-AF48-98FFA8F80856Q41818218-C6E4F22E-918B-4E8C-9745-B73044D8AA1FQ42830623-FC75B2D6-61E8-4E90-959D-208D1F0C126BQ45354358-FA941C79-BB0A-4BEF-BA96-84196D7CCD71Q46391524-354AEF23-373B-47E9-A0F2-0C4322F77515
P2860
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@ast
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@en
type
label
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@ast
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@en
prefLabel
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@ast
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@en
P2093
P2860
P356
P1476
IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.
@en
P2093
Aaron M Gibson
Fred D Finkelman
Gurjit K Khurana Hershey
Matthew T Stier
Umasundari Sivaprasad
Weiguo Chen
Yasuhiro Tabata
P2860
P304
P356
10.4049/JIMMUNOL.0901028
P407
P577
2009-12-01T00:00:00Z